1. HIV drug resistance against strand transfer integrase inhibitors;Anstett;Retrovirology,2017
2. World Health Organization. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. 2017. https://www.who.int/hiv/pub/guidelines/advanced-HIV-disease/en/.
3. European AIDS Clinical Society. EACS guidelines version 11.0. 2021. https://www.eacsociety.org/media/final2021eacsguidelinesv11.0_oct2021.pdfhttps://www.eacsociety.org/media/final2021eacsguidelinesv11.0_oct2021.pdf
4. DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. 2021. https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf.
5. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials